SCHEMBL24239116

SCHEMBL24239116

c1ccc2c(-c3cccc4c3oc3cccc(-c5nc(-c6ccc(-c7cccc8c7sc7c9ccccc9ccc87)cc6)nc(-c6ccc7c8ccccc8c8ccccc8c7c6)n5)c34)cccc2c1

nearest known ligand 0.32

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 2/20 0.32
▸ CYP1B1 Q16678 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ ALOX5 P09917 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ NFKB2 Q00653 1/20 0.31
▸ RELA Q04206 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21425240 0.91 ALOX5 (0.39) ALOX5KDM4EALDH1A1TP53MAPT
SCHEMBL25132286 0.90 CYP1A1 (0.33) CYP1A1CYP1B1CYP1A2ALOX5KDM4E
SCHEMBL23820595 0.89 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2ALOX5KDM4E
SCHEMBL24239122 0.87 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2ALOX5KDM4E
SCHEMBL23819368 0.87 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL24239144 0.86 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2ALOX5KDM4E
SCHEMBL21425104 0.86 ALOX5 (0.39) ALOX5KDM4EALDH1A1TP53MAPT
SCHEMBL25586448 0.85 ALOX5 (0.36) ALOX5KDM4EALDH1A1MAPTTSHR
SCHEMBL24239114 0.85 CYP1A1 (0.35) CYP1A1CYP1B1CYP1A2ALOX5KDM4E
SCHEMBL24930431 0.85 MAPT (0.40) CYP1A1CYP1B1CYP1A2ALOX5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-24 — — US disclosed
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-24 — — US disclosed
US-20230115134-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-13 — — US disclosed
US-20220037594-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-02-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230115134-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, OR10J3 CYP1A1 897/4885CYP1B1 2461/4885CYP1A2 762/4885
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof PIEZO1, ORAI2, OCIAD1 CYP1A1 787/4885CYP1B1 1728/4885CYP1A2 844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback